InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（16 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
16
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Cohen Joshua B, 董事长兼首席执行官. Insider active across 1 company, notably Amylyx Pharmaceuticals, Inc.. Aggregated, 28 reports have been logged. Split: 0 buy · 16 sells. Total volume traded: €6.1m. History available since 6 January 2022. The latest transaction was disclosed on 18 August 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Cohen Joshua B
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报28 总计
60,039 股0Common StockSEC:0001193125-26-359675:0
248,865 股0Common StockSEC:0001193125-26-098440:0
29,282 股@ US$14.4844.7% 占其流量Common StockSEC:0001193125-26-091442:0
15,500 股@ US$14.68342.5% 占其流量Common StockSEC:0001193125-26-037552:0
197,182 股@ US$7.5719.3% 占其流量Common StockSEC:0001193125-26-017057:0
136,193 股@ US$13.589524.0% 占其流量Common StockSEC:0001193125-26-017057:1
2,818 股@ US$7.570.3% 占其流量Common StockSEC:0001193125-26-017057:2
1,974 股@ US$13.82930.4% 占其流量Common StockSEC:0001193125-26-017057:3
7,715 股@ US$11.09481.0% 占其流量Common StockSEC:0001193125-26-007666:0
29,733 股@ US$14.34335.2% 占其流量Common StockSEC:0001193125-25-228340:0
21,490 股@ US$3.46591.0% 占其流量Common StockSEC:0000950170-25-049513:0
180,118 股0Common StockSEC:0000950170-25-036708:0
4,595 股@ US$3.16630.2% 占其流量Common StockSEC:0000950170-25-033719:0
11,851 股@ US$3.46870.6% 占其流量Common StockSEC:0000950170-25-014610:0
7,471 股@ US$4.04660.4% 占其流量Common StockSEC:0000950170-25-003531:0
18,589 股@ US$3.19620.8% 占其流量Common StockSEC:0000950170-24-111811:0
1,857 股@ US$1.570.0% 占其流量Common StockSEC:0000950170-24-109397:0
34,449 股@ US$1.570.7% 占其流量Common StockSEC:0000950170-24-106915:0
179,850 股0Common StockSEC:0000950170-24-045696:0
4,135 股@ US$18.72791.1% 占其流量Common StockSEC:0000950170-24-027923:0
126,667 股0Common StockSEC:0000950170-24-022413:0
5,841 股@ US$16.32811.3% 占其流量Common StockSEC:0000950170-24-003981:0
63,694 股@ US$1.571.4% 占其流量Common StockSEC:0000950170-23-065259:0
96,076 股@ US$31.839643.6% 占其流量Common StockSEC:0000899243-23-009171:0
4,122 股@ US$36.07892.1% 占其流量Common StockSEC:0000899243-23-001524:0
28 条申报中的 25 条
About Cohen Joshua B
Cohen Joshua B is Co-Président-Directeur Général and Co-Chief Executive Officer at Amylyx Pharmaceuticals, Inc. He has filed 27 disclosures in total, and across the sampled recent filings from 2022-01-10 to 2026-03-09, the dominant transaction type is selling, with EUR 0 of buys and EUR 6,062,202 of sales.
